Assessment of Training on Culture and Drug Sensitivity Testing of Mycobacterium tuberculosis at a National Reference Laboratory

Autor: S. Prabuseenivasan, Selvakumar N, Uma Devi Kr, P. Nagarajan, Radhakrishnan R, Ponnuraja C, Balaji S, Sangamithirai D, Kumar

Publikováno v: Mycobacterial Diseases.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6993711a7bdab79879cb82e5637d30b3
https://doi.org/10.4172/2161-1068.1000264

Unique cellular immune signatures of multisystem inflammatory syndrome in children.

Autor: Rajamanickam A; National Institutes of Health-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai, India., Nathella PK; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Venkataraman A; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Varadarjan P; Institute of Child Health and Hospital for Children, Chennai, India., Kannan S; Institute of Child Health and Hospital for Children, Chennai, India., Pandiarajan AN; National Institutes of Health-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai, India., Renji RM; National Institutes of Health-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai, India., Elavarasan E; Dr Mehta's Children's Hospital, Chennai, India., Thimmaiah A; Dr Mehta's Children's Hospital, Chennai, India., Sasidaran K; Dr Mehta's Children's Hospital, Chennai, India., Krishnamoorthy N; Dr Mehta's Children's Hospital, Chennai, India., Natarajan S; Rainbow Children's Hospital, Chennai, India., Ramaswamy G; Rainbow Children's Hospital, Chennai, India., Sundaram B; Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India., Putlibai S; Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India., Hissar S; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Selladurai E; Institute of Child Health and Hospital for Children, Chennai, India., Uma Devi KR; ICMR-National Institute for Research in Tuberculosis, Chennai, India., Nutman TB; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Babu S; National Institutes of Health-National Institute for Research in Tuberculosis-International Center for Excellence in Research, Chennai, India.; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2022 Nov 02; Vol. 18 (11), pp. e1010915. Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2022).

4-month moxifloxacin containing regimens in the treatment of patients with sputum-positive pulmonary tuberculosis in South India - a randomised clinical trial.

Autor: Velayutham B; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Jawahar MS; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Nair D; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Navaneethapandian P; ICMR- National Institute for Research in Tuberculosis, Madurai, India., Ponnuraja C; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Chandrasekaran K; ICMR- National Institute for Research in Tuberculosis, Madurai, India., Narayan Sivaramakrishnan G; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Makesh Kumar M; ICMR- National Institute for Research in Tuberculosis, Madurai, India., Paul Kumaran P; ICMR- National Institute for Research in Tuberculosis, Madurai, India., Ramesh Kumar S; ICMR- National Institute for Research in Tuberculosis, Madurai, India., Baskaran D; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Bella Devaleenal D; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Sirasanambati DR; ICMR- National Institute for Research in Tuberculosis, Vellore, India., Vasantha M; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Palaniyandi P; ICMR- National Institute for Research in Tuberculosis, Madurai, India., Ramachandran G; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Uma Devi KR; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Elizabeth Hannah L; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Sekar G; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Radhakrishnan A; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Kalaiselvi D; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Dhanalakshmi A; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Thiruvalluvan E; ICMR- National Institute for Research in Tuberculosis, Madurai, India., Raja Sakthivel M; ICMR- National Institute for Research in Tuberculosis, Madurai, India., Mahilmaran A; Institute of Thoracic Medicine, Chennai, India., Sridhar R; Government Hospital for Thoracic Medicine, Chennai, India., Jayabal L; Revised National TB Control Programme, Chennai, India., Rathinam P; Government Rajaji Hospital, Madurai, India., Angamuthu P; Government Vellore Medical College Hospital, Vellore, India., Soorappa Ponnusamy K; Government Vellore Medical College Hospital, Vellore, India., Venkatesan P; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Natrajan M; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Prasad Tripathy S; ICMR- National Institute for Research in Tuberculosis, Chennai, India., Swaminathan S; World Health Organization, Geneva, Switzerland.

Publikováno v: Tropical medicine & international health : TM & IH [Trop Med Int Health] 2020 Apr; Vol. 25 (4), pp. 483-495. Date of Electronic Publication: 2020 Feb 03.

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles.

Autor: Kumarasingam K; Department of Microbiology, SRM Medical College Hospital and Research Centre, Kancheepuram, India., Vincent M; Department of Microbiology, SRM Medical College Hospital and Research Centre, Kancheepuram, India., Mane SR; Department of Chemical Sciences, Polymer Research Centre, India Institute of science Education and Research, Kolkata, West Bengal, India., Shunmugam R; Department of Chemical Sciences, Polymer Research Centre, n Institute of science Education and Research, Kolkata, West Bengal, India., Sivakumar S; Department of Bacteriology, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India., Uma Devi KR; Department of Bacteriology, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.

Publikováno v: International journal of mycobacteriology [Int J Mycobacteriol] 2018 Jan-Mar; Vol. 7 (1), pp. 84-88.

Improved diagnosis of pulmonary tuberculosis by detection of free and immune complex-bound anti-30 kDa antibodies.

Autor: Raja A; Department of Immunology, Tuberculosis Research Centre (ICMR), Chennai, India. alameluraja@yahoo.com, Uma Devi KR, Ramalingam B, Brennan PJ

Publikováno v: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2004 Dec; Vol. 50 (4), pp. 253-9.